Humana (HUM) Net Cash Flow (2009 - 2026)

Humana (HUM) has reported Net Cash Flow for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 1024.76% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $2.9 billion, a 295.28% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 180.02% from the prior year.
• Net Cash Flow was $1.9 billion for Q2 2026 at Humana, up from $751.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $8.7 billion in Q1 2023 and troughed at -$10.5 billion in Q4 2023.
• A 5-year average of $194.4 million and a median of $553.5 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow slumped 833.74% in 2022 and jumped 1024.76% in 2026, its largest moves.
• Over 5 years, Net Cash Flow stood at -$8.5 billion in 2022, then retreated by 23.03% to -$10.5 billion in 2023, then soared by 72.31% to -$2.9 billion in 2024, then jumped by 58.96% to -$1.2 billion in 2025, then surged by 263.47% to $1.9 billion in 2026.
• The last three Net Cash Flow figures came in at $1.9 billion (Q2 2026), $751.0 million (Q1 2026), and -$1.2 billion (Q4 2025), per Business Quant data.